3431 related articles for article (PubMed ID: 19555948)
21. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
22. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
23. Mucosectomy for high-grade dysplasia in Barrett's esophagus.
Picasso M; Blanchi S; Filiberti R; Di Muzio M; Conio M
Minim Invasive Ther Allied Technol; 2006; 15(6):325-30. PubMed ID: 17190656
[TBL] [Abstract][Full Text] [Related]
24. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
25. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.
Giovannini M; Bories E; Pesenti C; Moutardier V; Monges G; Danisi C; Lelong B; Delpero JR
Endoscopy; 2004 Sep; 36(9):782-7. PubMed ID: 15326573
[TBL] [Abstract][Full Text] [Related]
26. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
27. Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report.
Pouw RE; Gondrie JJ; Curvers WL; Sondermeijer CM; Ten Kate FJ; Bergman JJ
Gastrointest Endosc; 2008 Sep; 68(3):537-41. PubMed ID: 18760181
[TBL] [Abstract][Full Text] [Related]
28. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
29. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
Sujendran V; Sica G; Warren B; Maynard N
Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
[TBL] [Abstract][Full Text] [Related]
30. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
[TBL] [Abstract][Full Text] [Related]
31. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic features of buried Barrett's mucosa.
Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF
Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency ablation of Barrett's esophagus: short-term results.
Eldaif SM; Lin E; Singh KA; Force SD; Miller DL
Ann Thorac Surg; 2009 Feb; 87(2):405-10; discussion 410-1. PubMed ID: 19161747
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of Barrett's high-grade dysplasia.
Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A
Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031
[TBL] [Abstract][Full Text] [Related]
35. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
[TBL] [Abstract][Full Text] [Related]
36. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.
Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD
Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
38. Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett's esophagus neoplasia.
Jayasekera C; Taylor AC; Desmond PV; Macrae F; Williams R
Endoscopy; 2012 Dec; 44(12):1089-95. PubMed ID: 23188660
[TBL] [Abstract][Full Text] [Related]
39. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
[TBL] [Abstract][Full Text] [Related]
40. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy.
Mino-Kenudson M; Hull MJ; Brown I; Muzikansky A; Srivastava A; Glickman J; Park DY; Zuckerberg L; Misdraji J; Odze RD; Lauwers GY
Gastrointest Endosc; 2007 Oct; 66(4):660-6; quiz 767, 769. PubMed ID: 17905005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
